Request Lapetus Life Expectancy Study Information

  • By clicking “Submit Request,” you acknowledge and agree that the Lapetus Life Expectancy Report is for informational purposes only.

  • This field is for validation purposes and should be left unchanged.

Press Releases

Coventry Responds to Lapetus’s Secrecy Claim

Coventry First LLC (“Coventry”), the market leader in life settlements, this week filed a legal response opposing Lapetus Solutions, Inc.’s (“Lapetus”) attempt to block disclosure of statutorily required life expectancy audit reports. The filing underscores Coventry’s long-held view that the integrity of the life settlement market demands transparency around the accuracy of life expectancy estimates. At the same time, Coventry filed its own motion for summary judgment, arguing that Lapetus’s announced shutdown on August 31, 2025, should eliminate any claim to trade secret protection.

READ MORE

Flaws in Lapetus Life Expectancy Estimates Exposed in New Study Following Olshansky-Buerger Debate at LISA Conference

A comprehensive new study conducted by Professors Daniel Bauer and Nan Zhu has revealed serious flaws in the life expectancy estimates produced by Lapetus Solutions, Inc., highlighting that the company significantly understates the actual life expectancies of insureds. The findings raise serious concerns about the accuracy of Lapetus’s mortality predictions, which could have serious repercussions for life settlement investors.

READ MORE

Coventry Releases Peer Review of Lapetus Life Expectancy Study

Coventry today released an independent, academic peer review confirming the results of an internal analysis of life expectancy estimates issued by leading life expectancy providers. That analysis found that estimates issued by Lapetus Solutions, Inc. are consistently the shortest by a wide margin—meaning that valuations based on Lapetus life expectancies could lead to significantly inflated asset values and investor losses.

READ MORE

Coventry Study Finds Lapetus Life Expectancies are Shorter than Competitors in 85% of Cases Reviewed

Coventry today released the results of an internal review that found life expectancy estimates issued by Lapetus Solutions, Inc. are consistently and materially shorter than those issued by other life expectancy providers, potentially leading to the overvaluation of life insurance policies and investor losses. The results cast doubt on the accuracy of asset valuations based primarily on Lapetus life expectancies.

READ MORE